[Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor].
Miura
K
K
Dept. of Urology, Akita Red-Cross Hospital.
Yuri
Y
Y
Tsukada
T
T
D000283:Administration, Intravesical; D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control* / Q000601:surgery; D003561:Cytarabine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011184:Postoperative Period; D001749:Urinary Bladder Neoplasms / Q000517:prevention & control* / Q000601:surgery
D008937:Mitomycins; D003561:Cytarabine; D016685:Mitomycin; D005047:Etoposide